On Mar. 12, 2020, Emory University announced it was participating in a National Institutes of Health (NIH) sponsored global clinical trial to evaluate the safety and efficacy of novel therapeutic agents in hospitalized adult patients diagnosed with COVID-19. The drug remdesivir was the first agent to be evaluated.